*7.1.1 GnRHa*

Gonadotropin-releasing hormone (GnRH) agonists have been shown to release pain and reduce the adenomyotic lesions' size [17].

GnRHa agonists cause hypoestrogenism, resulting in adverse effects such as hot flashes, vaginal dryness, and bone mineral loss.
